Related Experiment Video
Updated: Dec 13, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Mutant KRAS Promotes NKG2D+ T Cell Infiltration and CD155 Dependent Immune Evasion
Kensuke Nishi1,2,3, Shuhei Ishikura1,4, Masayo Umebayashi5
1Department of Cell Biology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Background/Aim:
Roles for mutant (mt) KRAS in the innate immune microenvironment in colorectal cancer (CRC) were explored.
Materials And Methods:
Human CRC HCT116-derived, mtKRAS-disrupted (HKe3) cells that express exogenous mtKRAS and allogenic cytokine-activated killer (CAK) cells were co-cultured in 3D floating (3DF) culture. The anti-CD155 antibody was used for function blocking and immuno histochemistry.
Results:
Infiltration of CAK cells, including NKG2D+ T cells, into the deep layer of HKe3-mtKRAS spheroids, was observed. Surface expression of CD155 was found to be up-regulated by mtKRAS in 3DF culture and CRC tissues. Further, the number of CD3+ tumor-infiltrating cells in the invasion front that show substantial CD155 expression was significantly larger than the number showing weak expression in CRC tissues with mtKRAS. CD155 blockade decreased the growth of spheroids directly and indirectly through the release of CAK cells.
Conclusion:
CD155 blockade may be useful for therapies targeting tumors containing mtKRAS.
Insights
Mutant KRAS in colorectal cancer (CRC) upregulates CD155, attracting immune cells. Blocking CD155 may offer a new therapy for CRC tumors with mutant KRAS.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Mutant KRAS (mtKRAS) plays a role in colorectal cancer (CRC) development.
- The innate immune microenvironment's interaction with mtKRAS in CRC is not fully understood.
Purpose of the Study:
- To investigate the role of mtKRAS in the innate immune microenvironment of CRC.
- To explore the potential of targeting CD155 for CRC therapy.
Main Methods:
- Co-culture of mtKRAS-expressing CRC cells (HKe3) with cytokine-activated killer (CAK) cells in 3D floating (3DF) culture.
- Utilized anti-CD155 antibody for function blocking and immunohistochemistry.
Main Results:
- Observed infiltration of CAK cells, including NKG2D+ T cells, into mtKRAS-expressing CRC spheroids.
- mtKRAS upregulates surface CD155 expression in 3DF culture and CRC tissues.
- CD155 blockade reduced spheroid growth directly and via CAK cell release, correlating with CD3+ cell infiltration in CRC tissues.
Conclusions:
- CD155 upregulation by mtKRAS influences immune cell infiltration in CRC.
- CD155 blockade demonstrates therapeutic potential for mtKRAS-driven CRC.
More Related Videos
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation

